Albumin microspheres as drug carriers

Area of Science:

• Biomedical Engineering
• Oncology
• Materials Science

Background:

• Improving the therapeutic index in cancer chemotherapy requires targeted delivery of antitumor agents.
• Nontoxic, biodegradable drug carriers are essential for effective drug delivery.
• Albumin microspheres represent a significant advancement in drug carrier technology.

Purpose of the Study:

• To review the progress in using albumin microspheres as drug carriers for cancer chemotherapy over the last 10-15 years.
• To cover the preparation, properties, pharmacokinetics, and efficacy of albumin microspheres in preclinical models.
• To assess the potential of intra-arterial administration of albumin microspheres for liver tumors.

Main Methods:

• Review of literature on albumin microsphere preparation and characterization.
• Analysis of pharmacokinetic studies in experimental animals.
• Evaluation of antitumor efficacy data, particularly for intra-arterial delivery in liver cancer models.

Main Results:

• Albumin microspheres have been successfully developed with controlled physicochemical properties for drug encapsulation.
• Pharmacokinetic studies demonstrate favorable biodistribution and sustained release profiles.
• Intra-arterial administration of albumin microspheres shows significant antitumor efficacy against experimental liver tumors.

Conclusions:

• Albumin microspheres are effective drug carriers for enhancing cancer chemotherapy.
• Their application, especially via intra-arterial delivery, shows promise for treating primary and metastatic liver tumors.
• Further research into albumin microsphere technology can optimize targeted cancer treatment strategies.